Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Radiotherapy with or without Hormone Therapy in Post-operative Prostate Cancer
NCT00949962Phase 3Terminated
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Oct 2009
- Primary completion
- Dec 2015
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of leuprolide in prostate cancer (PCa) (2 arms), sponsored by European Organisation for Research and Treatment of Cancer. Primary endpoint: Biochemical Progression-Free Survival. Started Oct 2009; status: terminated.
02
Drugs
leuprolide
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00949962.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00949962.